about
Sortase A utilizes an ancillary protein anchor for efficient cell wall anchoring of pili in Streptococcus agalactiaeGroup B Streptococcus vaccine: state of the artImmunogenic properties of Streptococcus agalactiae FbsA fragmentsUnderstanding the regulation of Group B Streptococcal virulence factorsRecent advances in understanding the molecular basis of group B Streptococcus virulenceAdaptive response of Group B streptococcus to high glucose conditions: new insights on the CovRS regulation networkEndocytosis‒Mediated Invasion and Pathogenicity of Streptococcus agalactiae in Rat Cardiomyocyte (H9C2)Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid testGram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary TractRemodeling of the Streptococcus agalactiae transcriptome in response to growth temperatureExtensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B streptococcus) in response to incubation with human blood.Identification of an unusual pattern of global gene expression in group B Streptococcus grown in human bloodGenetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area.Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model.Pilus distribution among lineages of group b streptococcus: an evolutionary and clinical perspectiveContribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain.Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactionsEnteral tube feeding alters the oral indigenous microbiota in elderly adults.Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.Essential role of interleukin-1 signaling in host defenses against group B streptococcus.Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonizationPrognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patientsClinical features of group B Streptococcus prosthetic joint infections and molecular characterization of isolates.The interleukin-1β/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection.Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B Streptococcus serotypes III and V.β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection.The role of autophagy during group B Streptococcus infection of blood-brain barrier endotheliumGroup B streptococcus and early-onset sepsis in the era of maternal prophylaxis.Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.RovS and its associated signaling peptide form a cell-to-cell communication system required for Streptococcus agalactiae pathogenesis.Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinantsGroup B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivoStreptococcus agalactiae infection in zebrafish larvaeImmune activation and suppression by group B streptococcus in a murine model of urinary tract infectionCharacterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults.Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model.Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.Variation in the number of tandem repeats and profile of surface protein genes among invasive group B Streptococci correlates with patient age.
P2860
Q24651230-74D52105-8322-4B60-94AD-F389F6EBECD1Q26796438-C9579727-7122-4C9D-802F-21F50715E9C3Q27305364-DE230891-2929-4C4A-8A8B-8656E9660B7FQ28237019-012AA39E-AD70-4889-87C8-2CA4C9B40D08Q28294474-BBBC3C6A-7162-4988-B7CB-6F46E4513DB1Q28486099-DF14EB27-B03C-4EA8-A201-4FC2F30AC19EQ28550027-D55F3706-1A43-4167-9073-496D5DE3E265Q28680724-EF065CE0-6E28-4CE5-BD3E-366384242B0DQ28829569-539C0973-F6A3-4E3C-A1FD-073BF815E6FFQ33355951-1D21D2F2-6628-474B-ABFE-7F97061BF32BQ33366465-B9806459-0013-4CDD-90B8-3E45D2D23DEDQ33506096-0A5CD0BE-1AE9-407E-A006-A6872E014712Q33587116-C34DBECC-6685-4EB3-B144-01CD83F41ECBQ33623814-F565B5D4-DDA3-4DA6-A98D-BBB84A63AD1AQ33820394-464F5B6C-37AA-4A7D-8C64-07D41A64E5F0Q33868597-B825B5FC-E2C7-49FE-B0C1-1523E952C0A0Q33911783-FDCD1B28-0DE9-47CC-8F6C-41EB50E90DE9Q33947220-3D0718C9-1F2E-413A-9FB4-9835F9627C37Q33984603-62F50414-61BA-4B93-A30C-9B021274310CQ34030735-553F88BA-8BF8-48C1-894F-17762EB3BD08Q34037817-30D93EB1-02BC-40A1-8FC2-4A58CA4BB06CQ34197495-F18A2900-4223-438E-8159-50C1317FFFCBQ34315633-429AAB03-DD54-462F-85EB-A80BFD37DF40Q34458308-B6423EDD-E574-4F7F-8990-0CA520C3FBDBQ34487365-72B1CE0D-89CD-439B-871A-6DC20A682A6CQ34596129-F7501563-BB19-4647-99A9-D39458C7D007Q34600971-4E131FCF-36D8-4567-B7AB-C0F0C601F9AFQ34626092-6E44A3EC-F382-4A83-9015-965D88891221Q34774424-5DDFFE12-7EBF-4637-AB9E-ED8D289C5700Q34985330-CBE8CA3D-AE65-43C0-B27B-61BCC993F650Q35004841-2BEDCB3A-7254-4C9C-9276-A32576320867Q35072320-1B8FD0DC-7CA4-49F5-883E-DCB51C3FCE8FQ35073801-23F221B3-4594-4C49-BBFA-30B8D8345EE0Q35082207-612C2BBA-2A36-47AB-9FB5-A263DBCD2F10Q35122423-E1C33DB8-01C1-4DE4-AB96-AA6A1705D206Q35191882-35A09B70-E8E6-43DD-B993-4C8C9ED929E3Q35273541-76C797E7-01AA-4D52-A34E-9105C83955AFQ35541855-E3F87C69-55A5-4EBF-AF73-013CCCAC1D45Q35609664-995308B0-99F7-4462-B379-713308FB3DFAQ35784477-02B1A9B1-AC32-4C18-90B6-3B1F9F91AD6C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Group B streptococcal infections in elderly adults.
@ast
Group B streptococcal infections in elderly adults.
@en
type
label
Group B streptococcal infections in elderly adults.
@ast
Group B streptococcal infections in elderly adults.
@en
prefLabel
Group B streptococcal infections in elderly adults.
@ast
Group B streptococcal infections in elderly adults.
@en
P2860
P356
P1476
Group B streptococcal infections in elderly adults.
@en
P2093
Carol J Baker
Morven S Edwards
P2860
P304
P356
10.1086/432804
P407
P577
2005-08-16T00:00:00Z